Issue Date: October 6, 2014
Aesica Being Sold To Device Firm
Aesica Pharmaceuticals, an English contract manufacturer built largely through acquisitions of former big pharma sites, is itself being acquired by Consort Medical, a British medical device maker, for about $370 million. Since its founding 10 years ago through the management-led buyout of a BASF facility, Aesica has pieced together European operations spanning pharmaceutical chemical manufacturing, formulation development, clinical trial supply, and finished-dosage production. Last year, Aesica’s sales approached $325 million. Consort, which makes devices for delivering inhaled, nasal, and injectable drugs, has annual sales of about $160 million.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society